STAT-Dx Overview
- Year Founded
-
2010

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$191M
- Investors
-
1
STAT-Dx General Information
Description
Manufacturer and developer of a point of care diagnostics device intended to support timely efficient patient care. The company's point of care diagnostics device, DiagCORE, is a portable multi-analyte instrument for molecular and immuno-assay testing for different clinical settings, enabling healthcare providers to consolidate molecular and immunoassay techniques in a single device.
Contact Information
Website
www.stat-dx.comCorporate Office
- Baldiri Reixac 4
- 08028 Barcelona
- Spain
Corporate Office
- Baldiri Reixac 4
- 08028 Barcelona
- Spain
STAT-Dx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 19-Apr-2018 | $191M | Completed | Generating Revenue | ||
5. Debt - General | 01-Jun-2017 | Completed | Generating Revenue | |||
4. Later Stage VC (Series C) | 30-Mar-2016 | Completed | Generating Revenue | |||
3. Early Stage VC (Series B) | 30-Mar-2016 | Completed | Startup | |||
2. Early Stage VC | 26-May-2014 | $11.7M | $14.5M | Completed | Startup | |
1. Early Stage VC (Series A) | 15-Jun-2011 | $2.87M | $2.87M | Completed | Startup |
STAT-Dx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | ||||||||
Series D | ||||||||
Series C | 17,735 | $1.113169 | $532.27 | $532.27 | 1x | $532.27 | 19.94% | |
Series B | 6,400 | $1.113169 | $347.87 | $347.87 | 1x | $347.87 | 7.19% |
STAT-Dx Comparisons
Industry
Financing
Details
STAT-Dx Competitors (16)
One of STAT-Dx’s 16 competitors is Nanomix, a Formerly VC-backed company based in San Leandro, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Nanomix | Formerly VC-backed | San Leandro, CA | ||||
Response Genetics | Corporate Backed or Acquired | Los Angeles, CA | ||||
Agendia | Venture Capital-Backed | Irvine, CA | ||||
ELITechGroup | Formerly PE-Backed | Puteaux, France | ||||
Accelerate Diagnostics | Corporation | Tucson, AZ |
STAT-Dx Patents
STAT-Dx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190217292-A1 | Dry chemistry container | Active | 18-Jan-2018 | ||
EP-3740316-A1 | Dry chemistry container | Pending | 18-Jan-2018 | ||
US-12042793-B2 | Dry chemistry container | Active | 18-Jan-2018 | ||
US-10843193-B2 | Dry chemistry container | Active | 17-Jul-2015 | ||
US-10919040-B2 | Method for sample separation and collection | Active | 17-Jul-2015 | B01L3/502753 |
STAT-Dx Former Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
AXIS Participaciones Empresariales | Corporate Venture Capital | Minority | ||
Boehringer Ingelheim Venture Fund | Corporate Venture Capital | Minority | ||
Caixa Capital Risc | Venture Capital | Minority | ||
Gilde Healthcare | Venture Capital | Minority | ||
Idinvest Partners | PE/Buyout | Minority |
STAT-Dx FAQs
-
When was STAT-Dx founded?
STAT-Dx was founded in 2010.
-
Where is STAT-Dx headquartered?
STAT-Dx is headquartered in Barcelona, Spain.
-
What industry is STAT-Dx in?
STAT-Dx’s primary industry is Diagnostic Equipment.
-
Is STAT-Dx a private or public company?
STAT-Dx is a Private company.
-
What is the current valuation of STAT-Dx?
The current valuation of STAT-Dx is
. -
What is STAT-Dx’s current revenue?
The current revenue for STAT-Dx is
. -
How much funding has STAT-Dx raised over time?
STAT-Dx has raised $69.1M.
-
Who are STAT-Dx’s investors?
AXIS Participaciones Empresariales, Boehringer Ingelheim Venture Fund, Caixa Capital Risc, Gilde Healthcare, and Idinvest Partners are 5 of 8 investors who have invested in STAT-Dx.
-
Who are STAT-Dx’s competitors?
Nanomix, Response Genetics, Agendia, ELITechGroup, and Accelerate Diagnostics are some of the 16 competitors of STAT-Dx.
-
When was STAT-Dx acquired?
STAT-Dx was acquired on 19-Apr-2018.
-
Who acquired STAT-Dx?
STAT-Dx was acquired by Qiagen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »